About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,038 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,038 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 701-720 of 4,038 trials

CompletedStudying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal TumorsRATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors identify biomarkers related to cancer.NCT01572467 CompletedErlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionPhase I trial to study the effectiveness of erlotinib in treating patients who have metastatic or unresectable solid tumors and liver or kidney dysfunction.NCT00030498·Chicago, Illinois

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

UnknownSUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive SurgeryAn international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in…NCT06223763·Madrid

TerminatedThe Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer SurvivorsMany individuals with ovarian cancer experience distress, fatigue, weakness, anxiety, and other symptoms that decrease quality of life.NCT03641287·Seattle, Washington

UnknownEvaluation of the Adhesion to the GENEPY NetworkIn order to best meet the needs of all those affected by the genetic risk of cancer in our region, it is important to identify the factors likely to influence the course leading…NCT03979612·Toulouse, Occitanie

RecruitingSurvivors Uniting for Remote Guided ExerciseThe goal of this research study is to look at how live, online group exercise compares to recorded videos for helping increase physical activity levels, improve physical fitness…NCT07290309·Fort Collins, Colorado

RecruitingA Study to Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian CancerThe goal of this clinical trial is to learn if OPB-101 is safe in platinum resistant ovarian cancer participants and also to find the optimal dose of OPB-101.NCT07030907·Detroit, Michigan and 3 others

CompletedFUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia StudyThis phase 2 clinical trial aims to evaluate the efficacy of Fulvestrant, an ER-antagonist, in women with estrogen receptor positive (ER+) low-grade gynecological cancers.NCT03926936·Grivegnée, Liège and 13 others

UnknownA Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsThis is a phase 1, Open-label, multicenter Dose Escalation study of BTP-114, a novel platinum product, in patients with advanced solid tumors and BRCA or other DNA repair mutation.NCT02950064·Sarasota, Florida and 7 others

CompletedScreening for Ovarian MalignancyOvarian cancer is the second most common gynecologic malignancy. In 2008, it was the seventh leading cause of cancer deaths in women worldwide.NCT06348784·Cairo

UnknownPPK Study Based on Quantitative Pharmacology in Patients With PamiprilThis is a non-intervention, prospective, one-arm, observational real-world clinical trial. The researchers plan to recruit at least 50 qualified patients.NCT05848648·Jinan, Shandong

CompletedRO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerThis phase II trial is studying the side effects and how well RO4929097 works in treating patients with recurrent and/or metastatic epithelial ovarian cancer, fallopian tube…NCT01175343·Beverly Hills, California and 11 others

TerminatedVitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal CancerThe purpose of this research is to study Vitamin D3 replacement for patients at high risk of developing ovarian, fallopian tube, or peritoneal cancer, and see if the Vitamin D3…NCT01744821·Chicago, Illinois and 1 other

UnknownOxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00004206·Leicester, England

RecruitingETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian CancersThis is an open-label, single-arm, investigator-initiated study conceived as a dose expansion cohort of the study D3-002, which evaluated ETC-159 in combination with pembrolizumab…NCT06513624·Singapore, Singapore and 1 other

CompletedGene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal CancerRATIONALE: Inserting the p53 gene into a person's cancer cells may improve the body's ability to fight cancer or make the cancer more sensitive to chemotherapy.NCT00003450·Dallas, Texas

CompletedTemozolomide and O6-benzylguanine in Treating Children With Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00020150·Bethesda, Maryland

CompletedSexual Health Integration in Treatment of Gynecological OncologyThe goal of this cross-section observational and questionary based study is to learn how geological cancer survivors perceive sexual health support given by health care…NCT06958068·Katowice, Silesian Voivodeship

UnknownIncrease Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative StrategiesObservational study is to increase surveillance for breast and ovarian cancers, also to determine targeted risk-reducing and preventative strategies.NCT03319290·Land O' Lakes, Florida

CompletedMifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerRATIONALE: Progesterone can cause the growth of ovarian epithelial cancer , primary peritoneal cancer, or fallopian tube cancer.NCT00459290·Los Angeles, California and 21 others

PreviousPage 36 of 202Next